Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

MicrobeTV

P. Offit, V. Racaniello

Unveiling the Facets of Post-Sepsis Syndrome: Physical and Neuropsyc…

Houston Methodist

D. Moran

H5N1 Outbreak: Are We Inching Closer to Human Transmissibility?

MedCram

R. Seheult

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

CDC Changes COVID Policy

MicrobeTV

P. Offit, V. Racaniello

CDC Guidelines for Seasonal Influenza Vaccines, How and When to Use …

MicrobeTV

D. Griffin, V. Racaniello

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello

Restoring Faith in Vaccines

MicrobeTV

P. Offit, V. Racaniello